Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 729 JPY 0.26% Market Closed
Market Cap: 425.9B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Kobayashi Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kobayashi Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Interest Income Expense
ÂĄ1.5B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
15%
Shiseido Co Ltd
TSE:4911
Interest Income Expense
ÂĄ8.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
42%
Rohto Pharmaceutical Co Ltd
TSE:4527
Interest Income Expense
ÂĄ2.3B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
11%
Kao Corp
TSE:4452
Interest Income Expense
ÂĄ2.9B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Kose Corp
TSE:4922
Interest Income Expense
ÂĄ450m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
F
Fancl Corp
TSE:4921
Interest Income Expense
-ÂĄ29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
425.9B JPY
Industry
Consumer products

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Intrinsic Value
6 884.48 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Kobayashi Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
1.5B JPY

Based on the financial report for Jun 30, 2024, Kobayashi Pharmaceutical Co Ltd's Interest Income Expense amounts to 1.5B JPY.

What is Kobayashi Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
15%

Over the last year, the Interest Income Expense growth was 142%. The average annual Interest Income Expense growth rates for Kobayashi Pharmaceutical Co Ltd have been 10% over the past three years , 19% over the past five years , and 15% over the past ten years .

Back to Top